Colfax Corporation(CFX)

Sector:

Industrials

Description:

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips. This segment sells its products through independent distributors and direct sales to the general industry, construction, infrastructure, transportation, energy, renewable energy, and medical and life sciences markets principally under the ESAB brand. The Medical Technology segment develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. Colfax Corporation was founded in 1860 and is headquartered in Wilmington, Delaware.

Current Price

$69.17

RSI

53.49

Market Capitalization:

6.7B

Beta:

2.137

Volume:

890,186

Analyst Target Price:

$ 52.57

Economiic Fair Price:


February 22, 2022
Q4
N/A
N/A
N/A
N/A
N/A
1.86 %
25.28
0.0239

27.51 %
85.16 %
94.10 %
23.57 %
21.29 %
-31.41 %

$ 3.9B
25.52 %
$ 3.1B
-7.71 %
$ 3.3B
-9.25 %
$ 3.7B
11.11 %
$ 3.3B
-9.51 %
$ 3.6B

$ 251.9M
34.58 %
$ 187.2M
3274.50 %
$ 5.5M
-96.46 %
$ 156.7M
4.48 %
$ 150M
-18.35 %
$ 183.7M

$ 165.4M
185.01 %
$ 58M
14.92 %
$ 50.5M
-72.38 %
$ 182.8M
1625.13 %
$ -12M
-105.76 %
$ 208M

News

Press Releases

Notable Dates